2-piperidone has been researched along with Glioblastoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| A Jamal, AR; Chan, KM; Kamaluddin, NF; Lam, KW; Rajab, NF; Razali, NSC | 1 |
| Chen, J; Hoffmann, M; Li, Y; Liu, L; MacGorman, K; Palmisano, M; Zhou, S | 1 |
| Botelho de Souza, LE; Brassesco, MS; de Oliveira, HF; Paiva, HH; Pezuk, JA; Roberto, GM; Tone, LG; Umezawa, K; Vieira, GM | 1 |
| Barboza, JN; da Nóbrega, FR; de Sousa, DP; Nascimento Sousa, SCS; Ozdemir, O; Turkez, H | 1 |
| Cho, HJ; Han, S; Her, NG; Lee, Y; Nam, DH; Oh, JW; Oh, YJ; Ryu, GH | 1 |
| Almeida, RN; Bezerra Filho, CDSM; Nóbrega, FRD; Ozdemir, O; Perez-Castillo, Y; Sousa, DP; Tejera, E; Turkez, H | 1 |
| Burzynski, SR; Janicki, T; Jurida, G; Khan, M; Larisma, CB; Lewy, RI; Paszkowiak, J; Szymkowski, B; Weaver, R | 1 |
| Hara, H; Hirohata, M; Maruiwa, H; Shigemori, M; Sugita, Y; Tsuda, H | 1 |
| Ames, MM; Buckner, JC; Cascino, TL; Figg, WD; Lim, S; Malkin, MG; Reed, E; Reid, JM; Tong, WP | 1 |
2 trial(s) available for 2-piperidone and Glioblastoma
| Article | Year |
|---|---|
Single-Dose Pharmacokinetics, Safety, and Tolerability of Avadomide (CC-122) in Subjects With Mild, Moderate, or Severe Renal Impairment.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Carcinoma, Hepatocellular; Case-Control Studies; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Female; Genetic Pleiotropy; Glioblastoma; Hematologic Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Piperidones; Quinazolinones; Renal Insufficiency; Safety; Severity of Illness Index; Ubiquitin-Protein Ligases | 2020 |
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma.
Topics: Adult; Antineoplastic Agents; Astrocytoma; Benzeneacetamides; Brain Neoplasms; Confusion; Disorders of Excessive Somnolence; Drug Administration Schedule; Drug Combinations; Female; Glioblastoma; Glutamine; Humans; Injections, Intravenous; Male; Middle Aged; Patient Selection; Phenylacetates; Piperidones; Seizures; Severity of Illness Index; Treatment Outcome | 1999 |
7 other study(ies) available for 2-piperidone and Glioblastoma
| Article | Year |
|---|---|
Curcumin piperidone derivatives induce anti-proliferative and anti-migratory effects in LN-18 human glioblastoma cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Curcumin; Glioblastoma; Humans; Piperidones | 2022 |
DTCM-glutarimide Delays Growth and Radiosensitizes Glioblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Glioblastoma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Piperidones; Radiation-Sensitizing Agents | 2018 |
Piplartine Analogues and Cytotoxic Evaluation against Glioblastoma.
Topics: Apoptosis; Biological Availability; Brain Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Piperidones; Plant Extracts | 2018 |
Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells.
Topics: Acetates; Apoptosis; Cell Line, Tumor; Enzyme Inhibitors; Glioblastoma; Humans; Imidazolines; Mutation; Nestin; Piperidones; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53; Zinc Finger E-box-Binding Homeobox 1 | 2018 |
NFBTA: A Potent Cytotoxic Agent against Glioblastoma.
Topics: Acrylamides; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dioxolanes; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Molecular Docking Simulation; Piperidones | 2019 |
Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiforme.
Topics: Adult; Benzeneacetamides; Brain Stem Neoplasms; Disease-Free Survival; Drug Combinations; Glioblastoma; Glutamine; Health Status; Humans; Male; Neoplasm Recurrence, Local; Phenylacetates; Piperidones; Survival Analysis; Time Factors; Treatment Outcome | 2004 |
The effect of Antineoplaston, a new antitumor agent on malignant brain tumors.
Topics: Adult; Antineoplastic Agents; Astrocytoma; Benzeneacetamides; Brain Neoplasms; Child; Drug Combinations; Female; Glioblastoma; Glioma; Glutamine; Humans; Male; Medulloblastoma; Middle Aged; Phenylacetates; Piperidones | 1995 |